GLB VARICELLA-ZOSTER VIRUS FLUORESCENT— 510(k) K842096

Name: FDA 510(k) clearance K842096
Creator: U.S. Food and Drug Administration
Published: 1985-01-07

Substantially Equivalent

Great Lakes Bioscience

FDA 510(k) clearance K842096 for GLB VARICELLA-ZOSTER VIRUS FLUORESCENT, Substantially Equivalent on 1985-01-07. Applicant: Great Lakes Bioscience. Device class: 2.

Clearance details

Applicant: Great Lakes Bioscience
Product code: Code GQX
Device class: Class 2
Regulation: 21 CFR 866.3900
Advisory panel: Microbiology
Date received: 1984-05-25
Decision date: 1985-01-07
Decision: Substantially Equivalent
Clearance type: Traditional
Location: St. Joseph, MI, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code GQX

view all

K951799 — VARICELLA-ZOSTER VIRUS DIRECT IMMUNOFLUORESCENCE ASSAY1996-03-20
K911301 — VZV IGM TEST1991-07-17
K883427 — VIRGO(R) VZV-IGG ELISA1989-03-10
K875358 — VZV TEST1988-03-31
K863317 — ENZYGNOST ANTI-VZV IGG TEST1987-04-22

Data sourced from openFDA. This site is unofficial and independent of the FDA.